Clinical Trial

OCTA in Cardiovascular Disease and Healthy Controls

Recruiting
View on ClinicalTrials.gov →
Summary
This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.
Trial Details
NCT Number NCT07359664
Lead Sponsor University of Erlangen-Nürnberg Medical School
Collaborators: German Diabetes Association
Conditions Patients With Cardiovascular Disease, Healthy Participants
Enrollment 64 participants
Start Date 2025-12-01
Primary Completion 2026-12 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-22